Isbn: 9798337394114 - human capital, innovation, and executive decision-making in pharma and medical device industries (7 resultados)

- Tapa blanda
Librería: PBShop.store UK, Fairford, GLOS, Reino UnidoPBShop.store UK
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 214,27
Envío por EUR 6,91Se envía de Reino Unido a Estados Unidos de AmericaCantidad disponible: Más de 20 disponibles
PAP. Condición: New. New Book. Shipped from UK. Established seller since 2000.

- Tapa blanda
Librería: PBShop.store US, Wood Dale, IL, Estados Unidos de AmericaPBShop.store US
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 224,67
Gastos de envío gratisSe envía dentro de Estados Unidos de AmericaCantidad disponible: Más de 20 disponibles
PAP. Condición: New. New Book. Shipped from UK. Established seller since 2000.

- Tapa blanda
Librería: California Books, Miami, FL, Estados Unidos de AmericaCalifornia Books
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 254,47
Gastos de envío gratisSe envía dentro de Estados Unidos de AmericaCantidad disponible: Más de 20 disponibles
Condición: New.

- Tapa blanda
- Impresión bajo demanda
Librería: Grand Eagle Retail, Bensenville, IL, Estados Unidos de AmericaGrand Eagle Retail
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 254,55
Gastos de envío gratisSe envía dentro de Estados Unidos de AmericaCantidad disponible: 1 disponible
Paperback. Condición: new. Paperback. The pharmaceutical and medical device industries operate in one of the most complex and highly regulated environments in the global economy. Rapid technological innovation, increasing regulatory scrutiny, pressure for cost containment, and growing expectations for patient safety and outcomes have fundamentally reshaped how organizations design strategies and make executive decisions. In parallel, digital transformation continues to redefine operational and clinical landscapes. Within this context, human capital has emerged as a critical driver of innovation, organizational resilience, and long-term competitiveness. Human Capital, Innovation, and Executive Decision-Making in Pharma and Medical Device Industries explores the intersection of human capital management, innovation processes, and executive decision-making in the pharmaceutical and medical device sectors. This book positions leadership, talent, organizational culture, and strategic governance as central elements shaping innovation performance and regulatory success. Integrating perspectives from management, engineering, healthcare, and organizational studies, it offers a comprehensive view of how executive decisions and human-centered strategies influence innovation outcomes in life sciences industries. Covering topics such as executive decision-making, regulated drug development, and workplace performance in healthcare, this book is a fundamental academic resource for graduate and doctoral students, medical device executives, R&D leaders, regulatory affairs professionals, healthcare innovation managers, and more. This item is printed on demand. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.…

- Tapa blanda
- Impresión bajo demanda
Librería: CitiRetail, Stevenage, Reino UnidoCitiRetail
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 224,80
Envío por EUR 43,54Se envía de Reino Unido a Estados Unidos de AmericaCantidad disponible: 1 disponible
Paperback. Condición: new. Paperback. The pharmaceutical and medical device industries operate in one of the most complex and highly regulated environments in the global economy. Rapid technological innovation, increasing regulatory scrutiny, pressure for cost containment, and growing expectations for patient safety and outcomes have fundamentally reshaped how organizations design strategies and make executive decisions. In parallel, digital transformation continues to redefine operational and clinical landscapes. Within this context, human capital has emerged as a critical driver of innovation, organizational resilience, and long-term competitiveness. Human Capital, Innovation, and Executive Decision-Making in Pharma and Medical Device Industries explores the intersection of human capital management, innovation processes, and executive decision-making in the pharmaceutical and medical device sectors. This book positions leadership, talent, organizational culture, and strategic governance as central elements shaping innovation performance and regulatory success. Integrating perspectives from management, engineering, healthcare, and organizational studies, it offers a comprehensive view of how executive decisions and human-centered strategies influence innovation outcomes in life sciences industries. Covering topics such as executive decision-making, regulated drug development, and workplace performance in healthcare, this book is a fundamental academic resource for graduate and doctoral students, medical device executives, R&D leaders, regulatory affairs professionals, healthcare innovation managers, and more. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.…

- Tapa blanda
- Impresión bajo demanda
Librería: AussieBookSeller, Truganina, VIC, AustraliaAussieBookSeller
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 292,92
Envío por EUR 32,88Se envía de Australia a Estados Unidos de AmericaCantidad disponible: 1 disponible
Paperback. Condición: new. Paperback. The pharmaceutical and medical device industries operate in one of the most complex and highly regulated environments in the global economy. Rapid technological innovation, increasing regulatory scrutiny, pressure for cost containment, and growing expectations for patient safety and outcomes have fundamentally reshaped how organizations design strategies and make executive decisions. In parallel, digital transformation continues to redefine operational and clinical landscapes. Within this context, human capital has emerged as a critical driver of innovation, organizational resilience, and long-term competitiveness. Human Capital, Innovation, and Executive Decision-Making in Pharma and Medical Device Industries explores the intersection of human capital management, innovation processes, and executive decision-making in the pharmaceutical and medical device sectors. This book positions leadership, talent, organizational culture, and strategic governance as central elements shaping innovation performance and regulatory success. Integrating perspectives from management, engineering, healthcare, and organizational studies, it offers a comprehensive view of how executive decisions and human-centered strategies influence innovation outcomes in life sciences industries. Covering topics such as executive decision-making, regulated drug development, and workplace performance in healthcare, this book is a fundamental academic resource for graduate and doctoral students, medical device executives, R&D leaders, regulatory affairs professionals, healthcare innovation managers, and more. This item is printed on demand. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.…

- Tapa blanda
- Impresión bajo demanda
Librería: AHA-BUCH GmbH, Einbeck, AlemaniaAHA-BUCH GmbH
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 318,78
Envío por EUR 35,00Se envía de Alemania a Estados Unidos de AmericaCantidad disponible: 2 disponibles
Taschenbuch. Condición: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - The pharmaceutical and medical device industries operate in one of the most complex and highly regulated environments in the global economy. Rapid technological innovation, increasing regulatory scrutiny, pressure for cost containment, and growing expectations for patient safety and outcomes have fundamentally reshaped how organizations design strategies and make executive decisions. In parallel, digital transformation continues to redefine operational and clinical landscapes. Within this context, human capital has emerged as a critical driver of innovation, organizational resilience, and long-term competitiveness. Human Capital, Innovation, and Executive Decision-Making in Pharma and Medical Device Industries explores the intersection of human capital management, innovation processes, and executive decision-making in the pharmaceutical and medical device sectors. This book positions leadership, talent, organizational culture, and strategic governance as central elements shaping innovation performance and regulatory success. Integrating perspectives from management, engineering, healthcare, and organizational studies, it offers a comprehensive view of how executive decisions and human-centered strategies influence innovation outcomes in life sciences industries. Covering topics such as executive decision-making, regulated drug development, and workplace performance in healthcare, this book is a fundamental academic resource for graduate and doctoral students, medical device executives, R&D leaders, regulatory affairs professionals, healthcare innovation managers, and more. …